Abstract：【Objective】To investigate the relationship between the expression of androgen receptor and p53 in the prognosis of three negative breast cancer.【Methods】From January 2010 to December 2011, the clinical data of 87 patients with TNBC (three negative group) and 231 patients without TNBC (non-three negative group) were collected. The expression of AR and p53 was detected by immunohistochemistry and its relationship with clinicopathological features and prognosis was analyzed .【Results】The positive rates of p53 and AR in the three negative group were 49.43 % (43/87) and 37.93 % (33/87), respectively, which were significantly higher than those in the non-three negative group p 33.77 % (78/231) and 27.3 % (63/231), the differences were statistically significant (χ2=9.451, P=0.025;χ2=8.287, P=0.031). The positive expression of AR was related to lymph node metastasis (P<0.05), the positive expression of p53 was related to histological grade and molecular type (P<0.05), there was no correlation between other markers and the positive expression of p53 and AR (P>0.05). The 5-year local recurrence rate and distant metastasis rate in the three negative group was significantly higher than those in the non-three negative group (P<0.05). The 5-year survival rate was significantly lower than that in non-three negative group (P<0.05).【Conclusion】The expression of p53 and AR in TNBC was up-regulated, which was related to the differentiation of tumor cells and the status of lymph node metastasis. p53 and AR can be used as predictors of prognosis in patients with breast cancer .
王展梅,宋玉华,玄甜甜. 雄激素受体、p53在三阴性乳腺癌中的表达及其意义[J]. 医学临床研究, 2018, 35(1): 76-78.
WANG Zhan-mei,SONG Yu-hua,XUAN Tian-tian. Expression of Androgen Receptor and p53 In the Prognosis of Three-Negative Breast Cancer. JOURNAL OF CLINICAL RESEARCH, 2018, 35(1): 76-78.
2018, Vol. 35 
